Merus N.V (MRUS) has a profit margin of -669.66%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2025
Trailing 12 months ending Sep 2025
Merus N.V (MRUS) currently reports a profit margin of -669.66% as of September 2025. That compares with -680.61% in the prior-year period — up 1.6% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Merus N.V's profit margin history and peer comparisons.
Merus N.V's profit margin increased from -680.61% to -669.66% — a 1.6% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Merus N.V's profit margin of -669.66% is lower than the Healthcare sector average of 15.58%. That is roughly 4397.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Merus N.V's current -669.66% should be judged against Healthcare norms (sector average: 15.58%) and against MRUS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -669.66%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Merus N.V, and consider following MRUS for alerts when major investors trade the stock.